4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001894562-25-000045
Options or other derivatives
- Director acquired 106,578 shares (grant or award)
- Director returned 106,578 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chung Wendy Director | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −13,510 | 0 | D | ||
| Chung Wendy Director | 2025-08-01 | Grant or award · Stock Option (right to buy) | +13,510 | 13,510 | D | ||
| Chung Wendy Director | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −9,006 | 0 | D | ||
| Chung Wendy Director | 2025-08-01 | Grant or award · Stock Option (right to buy) | +9,006 | 9,006 | D | ||
| Chung Wendy Director | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −39,062 | 0 | D | ||
| Chung Wendy Director | 2025-08-01 | Grant or award · Stock Option (right to buy) | +39,062 | 39,062 | D | ||
| Chung Wendy Director | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −45,000 | 0 | D | ||
| Chung Wendy Director | 2025-08-01 | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | D | ||
Loading xslF345X05/wk-form4_1754440974.xml…